Filing Details

Accession Number:
0001382963-17-000080
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-12 16:38:07
Reporting Period:
2017-05-11
Filing Date:
2017-05-12
Accepted Time:
2017-05-12 16:38:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1460702 Ritter Pharmaceuticals Inc RTTR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1316386 D Michael Step Ritter Pharmaceuticals, Inc.
1801 Century Park East, #1820
Los Angeles, CA 90067
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-11 13,000 $0.62 50,000 No 4 P Indirect By Michael D. Step Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Michael D. Step Family Trust
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6102 to $0.6199, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.